Tiludronate as a new therapeutic agent in the treatment of navicular disease: A double-blind placebo-controlled clinical trial

Equine Veterinary Journal

Volumn 35, Issue 4, 2003, Pages 407-413

  Denoix, J M ^a   Thibaud, D ^b   Riccio, B ^c  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b CEVA SANTÉ ANIMALE   (France)

^c Fac of Vet Medicine of Perugia   (Italy)

Author keywords

Bisphosphonates; Bone; Clinical trial; Horse; Navicular disease; Osteolysis; Remodelling; Tiludronate

Indexed keywords

PLACEBO; TILUDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; BONE DISEASE; BONE METABOLISM; BONE REMODELING; CHRONIC DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HORSE; INJECTION; LOW DRUG DOSE; MALE; NONHUMAN; REGULATORY MECHANISM; REVIEW; SCAPHOID BONE; VIDEORECORDING; ANIMAL; ANIMAL DISEASE; ANIMAL LAMENESS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FOOT DISEASE; HOOF AND CLAW; HORSE DISEASE; INTRAVENOUS DRUG ADMINISTRATION; OSTEITIS; OSTEOLYSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

ANIMALS; BONE RESORPTION; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOOT DISEASES; HOOF AND CLAW; HORSE DISEASES; HORSES; INJECTIONS, INTRAVENOUS; LAMENESS, ANIMAL; MALE; OSTEITIS; TREATMENT OUTCOME; VIDEO RECORDING;

EID: 0242335224     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516403776014226     Document Type: Review

References (20)

1. Bonjour, J.P., Ammann, P., Barbier, A., Caverzasio, J. and Rizzoli, R. (1995) Tiludronate: Pharmacology and safety. Bone 17, 473S-477S
2. Chappard, D., Minaire, P., Privat, C., Berard, E., Mendoza-Sarmiento, J., Tournebise, H., Basle, M.F., Audran, M., Rebel, A., Picot, C. and Gaud, C. (1995) Effects of tiludronate on bone loss in paraplegic patients. J. Bone Min. Res. 10, 112-118.
3. Davi, H., Tronquet, C., Caix, J., Simiand, J., Briot, C., Berger, Y. and Thiercelin, J.F. (1999) Disposition of tiludronate (Skelid) in animals. Xenobiotica 29, 1017-1031.
4. Fleisch, H. (1998) Bisphosphonates : mechanism of action. Endocr. Rev. 19, 80-100.
5. Fraser, W.D., Stamp, T.C., Creek, R.A., Sawyer, J.P. and Picot, C. (1997) A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone. Postgrad. Med. J. 73, 496-502.
6. Fricker, C., Hugelshofer, J. and Attinger, P. (1986) Cibacalcin®: Ein neues Medikament zur Therapie der Strahlbeinlahmheit (Podotrochlose) des Pferdes. Prakt. Tier. 67, 572.
7. Huiskes, R., Rulmerman, R., van Lenthe, G.H. and Janssen, J.D. (2000) Effects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature 405, 704-706.
8. Jee, W.S.S. (2001) Integrated bone tissue physiology: anatomy and physiology. In: Bone Mechanics Handbook, 2nd edn., Ed: S.C. Cowin, CRC Press, Boca Raton, pp 1.1-1.68.
9. Mannix, K., Hjelmeland Ahmedzai, S., Anderson, H., Bennett, M., Lloyd-Williams, M. and Wilcock, A. (2000) Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care. Palliat. Med. 15, 141-147.
10. McGuigan, M.P., Cauvin, E., Schramme, M.C., Pardoe, C.H., May, S.A. and Wilson, A.M. (2000) A double-blind placebo-controlled trial of bisphosphonate in the treatment of navicular syndrome. In: Proceedings of the 39th British Equine Veterinary Association Congress, Equine Veterinary Journal Ltd, Newmarket. p 207.
11. Østblom, L., Lund, C. and Melsen, F. (1982) Histological study of navicular bone disease. Equine vet. J. 14, 199-202.
12. Østblom, L., Lund, C. and Melsen, F. (1989) Navicular bone disease : a comparative histomorphometric study. Equine vet. J. 21, 431-433.
13. Pool, R.R., Meagher, D.M. and Stover, S.M. (1989) Pathophysiology of navicular syndrome. Vet. Clin. N. Am.: Equine Pract. 5, 109-129.
14. Poulos, P.W. (1983) Correlation of radiographic signs and histologic changes in navicular disease. Proc. Am. Ass. equine Practnrs. 29, 241-255.
15. Rogers, M.J., Frith, J.C., Luckman, S.P., Coxon, F.P., Benford, H.L., Mönkkönen, J., Auriola, S., Chilton, K.M. and Russell, R.G.G. (1999) Molecular mechanisms of action of bisphosphonates. Bone 24, 73S-79S.
16. Rose, R.J. (1996) Navicular disease in the horse. J. equine vet. Sci. 16, 18-24.
17. Turner, A.S. and Tucker, C.M. (1989) The evaluation of isoxsuprine hydrochloride for the treatment of navicular disease: a double blind study. Equine vet. J. 21, 338-341.
18. Wilson, A.M., McGuigan, M.P., Fouracre, L. and McMahon, L. (2001) The force and contact stress on the navicular bone during trot locomotion in sound horses and horses with navicular disease. Equine vet. J. 33, 159-165.
19. Woo, T. and Adachi, J.D. (2001) Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis. Best Pract. Res. clin. Rheumatol. 15, 469-481.
20. Wright, I.M., Kidd, L. and Thorp, B.H. (1998) Gross, histological and histomorphometric features of the navicular bone and related structures in the horse. Equine vet. J. 30, 220-234.